메뉴 건너뛰기




Volumn 250, Issue , 2016, Pages 59-67

Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation

Author keywords

Chrysin; Diabetes; GW9662; Isoproterenol; Myocardial injury; PPAR

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CASPASE 3; CATALASE; CHRYSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUTATHIONE; I KAPPA B KINASE BETA; ISOPRENALINE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCATION END PRODUCT; AGER PROTEIN, MOUSE; ANTIOXIDANT; CARDIOTONIC AGENT; FLAVONOID;

EID: 84962597961     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.03.015     Document Type: Article
Times cited : (102)

References (39)
  • 1
    • 33746920337 scopus 로고    scopus 로고
    • Advanced glycation end products: Sparking the development of diabetic vascular injury
    • A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: Sparking the development of diabetic vascular injury Circulation 114 2006 597 605
    • (2006) Circulation , vol.114 , pp. 597-605
    • Goldin, A.1    Beckman, J.A.2    Schmidt, A.M.3    Creager, M.A.4
  • 2
    • 77950898257 scopus 로고    scopus 로고
    • The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
    • S.F. Yan, R. Ramasamy, and A.M. Schmidt The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature Circ. Res. 106 2010 842 853
    • (2010) Circ. Res. , vol.106 , pp. 842-853
    • Yan, S.F.1    Ramasamy, R.2    Schmidt, A.M.3
  • 3
    • 84885153340 scopus 로고    scopus 로고
    • Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
    • G. Daffu, C.H. delPozo, and K.M. O'Shea Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond Int. J. Mol. Sci. 14 2013 19891 19910
    • (2013) Int. J. Mol. Sci. , vol.14 , pp. 19891-19910
    • Daffu, G.1    DelPozo, C.H.2    O'Shea, K.M.3
  • 4
    • 84880176927 scopus 로고    scopus 로고
    • Nox as a target for diabetic complications
    • Y. Gorin, and K. Block Nox as a target for diabetic complications Clin. Sci. Lond. 125 2013 361 382
    • (2013) Clin. Sci. Lond. , vol.125 , pp. 361-382
    • Gorin, Y.1    Block, K.2
  • 6
    • 84922654302 scopus 로고    scopus 로고
    • AGEs and chronic subclinical inflammation in diabetes: Disorders of immune system
    • H. Hu, H. Jiang, H. Ren, X. Hu, X. Wang, and C. Han AGEs and chronic subclinical inflammation in diabetes: Disorders of immune system Diabetes Metab. Res. Rev. 31 2015 127 137
    • (2015) Diabetes Metab. Res. Rev. , vol.31 , pp. 127-137
    • Hu, H.1    Jiang, H.2    Ren, H.3    Hu, X.4    Wang, X.5    Han, C.6
  • 7
    • 0036599334 scopus 로고    scopus 로고
    • Advanced glycation end products and endothelial dysfunction in type 2 diabetes
    • K.C. Tan, W.S. Chow, V.H. Ai, C. Metz, R. Bucala, and K.S. Lam Advanced glycation end products and endothelial dysfunction in type 2 diabetes Diabetes Care 25 2002 1055 1059
    • (2002) Diabetes Care , vol.25 , pp. 1055-1059
    • Tan, K.C.1    Chow, W.S.2    Ai, V.H.3    Metz, C.4    Bucala, R.5    Lam, K.S.6
  • 8
    • 84903698784 scopus 로고    scopus 로고
    • Role of AGEs-RAGE system in cardiovascular disease
    • K. Fukami, S. Yamagishi, and S. Okuda Role of AGEs-RAGE system in cardiovascular disease Curr. Pharm. Des. 20 2014 2395 2402
    • (2014) Curr. Pharm. Des. , vol.20 , pp. 2395-2402
    • Fukami, K.1    Yamagishi, S.2    Okuda, S.3
  • 11
    • 84919969049 scopus 로고    scopus 로고
    • Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL)
    • N.M. Hanssen, J.W. Beulens, S. van Dieren, J.L. Scheijen, D.L. van der A, A.M. Spijkerman, Y.T. van der Schouw, C.D. Stehouwer, and C.G. Schalkwijk Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL) Diabetes 64 2015 257 265
    • (2015) Diabetes , vol.64 , pp. 257-265
    • Hanssen, N.M.1    Beulens, J.W.2    Van Dieren, S.3    Scheijen, J.L.4    Van Der, A.D.L.5    Spijkerman, A.M.6    Van Der Schouw, Y.T.7    Stehouwer, C.D.8    Schalkwijk, C.G.9
  • 12
    • 67651099181 scopus 로고    scopus 로고
    • Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
    • S. Yamagishi, K. Nakamura, and T. Matsui Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease Pharmacol. Res. 60 2009 174 178
    • (2009) Pharmacol. Res. , vol.60 , pp. 174-178
    • Yamagishi, S.1    Nakamura, K.2    Matsui, T.3
  • 13
    • 77952784059 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
    • S.H. Ihm, K. Chang, H.Y. Kim, S.H. Baek, H.J. Youn, K.B. Seung, and J.H. Kim Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor Basic Res. Cardiol. 105 2010 399 407
    • (2010) Basic Res. Cardiol. , vol.105 , pp. 399-407
    • Ihm, S.H.1    Chang, K.2    Kim, H.Y.3    Baek, S.H.4    Youn, H.J.5    Seung, K.B.6    Kim, J.H.7
  • 14
    • 51449089179 scopus 로고    scopus 로고
    • Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
    • S. Yamagishi, T. Matsui, K. Nakamura, M. Takeuchi, and H. Inoue Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation Protein Pept. Lett. 15 2008 850 853
    • (2008) Protein Pept. Lett. , vol.15 , pp. 850-853
    • Yamagishi, S.1    Matsui, T.2    Nakamura, K.3    Takeuchi, M.4    Inoue, H.5
  • 15
    • 84921386189 scopus 로고    scopus 로고
    • Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells
    • B.B. Di, H.W. Li, W.P. Li, X.H. Shen, Z.J. Sun, and X. Wu Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells Mol. Med. Rep. 11 2015 2601 2607
    • (2015) Mol. Med. Rep. , vol.11 , pp. 2601-2607
    • Di, B.B.1    Li, H.W.2    Li, W.P.3    Shen, X.H.4    Sun, Z.J.5    Wu, X.6
  • 16
    • 0035805144 scopus 로고    scopus 로고
    • Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages
    • Y.C. Liang, S.H. Tsai, D.C. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages FEBS Lett. 496 2001 12 18
    • (2001) FEBS Lett. , vol.496 , pp. 12-18
    • Liang, Y.C.1    Tsai, S.H.2    Tsai, D.C.3    Lin-Shiau, S.Y.4    Lin, J.K.5
  • 18
    • 84926126053 scopus 로고    scopus 로고
    • Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation
    • H.M. El-Bassossy, S.M. Abo-Warda, and A. Fahmy Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation Am. J. Chin. Med. 42 2014 1153 1167
    • (2014) Am. J. Chin. Med. , vol.42 , pp. 1153-1167
    • El-Bassossy, H.M.1    Abo-Warda, S.M.2    Fahmy, A.3
  • 19
    • 84928730981 scopus 로고    scopus 로고
    • Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism
    • N. Rani, S. Bharti, J. Bhatia, A. Tomar, T.C. Nag, R. Ray, and D.S. Arya Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism Nutr. Metab. Lond. 12 2015 11
    • (2015) Nutr. Metab. Lond. , vol.12 , pp. 11
    • Rani, N.1    Bharti, S.2    Bhatia, J.3    Tomar, A.4    Nag, T.C.5    Ray, R.6    Arya, D.S.7
  • 20
    • 84886288001 scopus 로고    scopus 로고
    • Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation
    • H.M. El-Bassossy, S.M. Abo-Warda, and A. Fahmy Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation Phytother. Res. 27 2013 1678 1684
    • (2013) Phytother. Res. , vol.27 , pp. 1678-1684
    • El-Bassossy, H.M.1    Abo-Warda, S.M.2    Fahmy, A.3
  • 21
    • 84902245181 scopus 로고    scopus 로고
    • Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats
    • A. Ahad, A.A. Ganai, M. Mujeeb, and W.A. Siddiqui Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats Toxicol. Appl. Pharmacol. 279 2014 1 7
    • (2014) Toxicol. Appl. Pharmacol. , vol.279 , pp. 1-7
    • Ahad, A.1    Ganai, A.A.2    Mujeeb, M.3    Siddiqui, W.A.4
  • 22
    • 0014606996 scopus 로고
    • Diabetogenic action of streptozotocin: Relationship of dose to metabolic response
    • A. Junod, A.E. Lambert, W. Stauffacher, and A.E. Renold Diabetogenic action of streptozotocin: Relationship of dose to metabolic response J. Clin. Investig. 48 1969 2129 2139
    • (1969) J. Clin. Investig. , vol.48 , pp. 2129-2139
    • Junod, A.1    Lambert, A.E.2    Stauffacher, W.3    Renold, A.E.4
  • 23
    • 84949845094 scopus 로고    scopus 로고
    • Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics
    • S.N. Goyal, N.M. Reddy, K.R. Patil, K.T. Nakhate, S. Ojha, C.R. Patil, and Y.O. Agrawal Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics Chem. Biol. Interact. 244 2016 49 63
    • (2016) Chem. Biol. Interact. , vol.244 , pp. 49-63
    • Goyal, S.N.1    Reddy, N.M.2    Patil, K.R.3    Nakhate, K.T.4    Ojha, S.5    Patil, C.R.6    Agrawal, Y.O.7
  • 24
    • 0018384650 scopus 로고
    • Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
    • H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
    • (1979) Anal. Biochem. , vol.95 , pp. 351-358
    • Ohkawa, H.1    Ohishi, N.2    Yagi, K.3
  • 25
    • 0018327389 scopus 로고
    • Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver
    • M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver Biochim. Biophys. Acta 582 1979 67 78
    • (1979) Biochim. Biophys. Acta , vol.582 , pp. 67-78
    • Moron, M.S.1    Depierre, J.W.2    Mannervik, B.3
  • 27
    • 0000024078 scopus 로고
    • Catalase
    • H.U. Bergmeyer, Academic Press Inc. New York
    • H. Aebi Catalase H.U. Bergmeyer, Methods of Enzymatic Analysis 1974 Academic Press Inc. New York 673 685
    • (1974) Methods of Enzymatic Analysis , pp. 673-685
    • Aebi, H.1
  • 28
    • 84891957173 scopus 로고    scopus 로고
    • Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion
    • N. Rani, S. Bharti, M. Manchanda, T.C. Nag, R. Ray, S.S. Chauhan, S. Kumari, and D.S. Arya Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion Plos One 8 2013 e82577
    • (2013) Plos One , vol.8 , pp. e82577
    • Rani, N.1    Bharti, S.2    Manchanda, M.3    Nag, T.C.4    Ray, R.5    Chauhan, S.S.6    Kumari, S.7    Arya, D.S.8
  • 29
    • 84924114114 scopus 로고    scopus 로고
    • 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: Role of MAPKs and HSPs
    • S. Bharti, N. Rani, J. Bhatia, and D.S. Arya 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: Role of MAPKs and HSPs Apoptosis 20 2015 455 465
    • (2015) Apoptosis , vol.20 , pp. 455-465
    • Bharti, S.1    Rani, N.2    Bhatia, J.3    Arya, D.S.4
  • 32
    • 44649151707 scopus 로고    scopus 로고
    • The PPAR trio: Regulators of myocardial energy metabolism in health and disease
    • J.A. Madrazo, and D.P. Kelly The PPAR trio: Regulators of myocardial energy metabolism in health and disease J. Mol. Cell. Cardiol. 44 2008 968 975
    • (2008) J. Mol. Cell. Cardiol. , vol.44 , pp. 968-975
    • Madrazo, J.A.1    Kelly, D.P.2
  • 33
    • 84864864825 scopus 로고    scopus 로고
    • PPAR-γ as a therapeutic target in cardiovascular disease: Evidence and uncertainty
    • J.V. Huang, C.R. Greyson, and G.G. Schwartz PPAR-γ as a therapeutic target in cardiovascular disease: Evidence and uncertainty J. Lipid Res. 53 2012 1738 1754
    • (2012) J. Lipid Res. , vol.53 , pp. 1738-1754
    • Huang, J.V.1    Greyson, C.R.2    Schwartz, G.G.3
  • 35
    • 85047682479 scopus 로고    scopus 로고
    • Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats
    • J. Sathiavelu, G.J. Senapathy, R. Devaraj, and N. Namasivayam Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats J. Pharm. Pharmacol. 61 2009 809 817
    • (2009) J. Pharm. Pharmacol. , vol.61 , pp. 809-817
    • Sathiavelu, J.1    Senapathy, G.J.2    Devaraj, R.3    Namasivayam, N.4
  • 36
    • 84890502277 scopus 로고    scopus 로고
    • Evaluation of the anti-atherogenic potential of chrysin in Wistar rats
    • R. Anandhi, P.A. Thomas, and P. Geraldine Evaluation of the anti-atherogenic potential of chrysin in Wistar rats Mol. Cell. Biochem. 385 2014 103 113
    • (2014) Mol. Cell. Biochem. , vol.385 , pp. 103-113
    • Anandhi, R.1    Thomas, P.A.2    Geraldine, P.3
  • 37
    • 84896698569 scopus 로고    scopus 로고
    • Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
    • E.M. Mantawy, W.M. El-Bakly, A. Esmat, A.M. Badr, and E. El-Demerdash Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis Eur. J. Pharmacol. 728 2014 107 118
    • (2014) Eur. J. Pharmacol. , vol.728 , pp. 107-118
    • Mantawy, E.M.1    El-Bakly, W.M.2    Esmat, A.3    Badr, A.M.4    El-Demerdash, E.5
  • 38
    • 84903453976 scopus 로고    scopus 로고
    • Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages
    • M. Warat, E. Szliszka, I. Korzonek-Szlacheta, W. Król, and Z.P. Czuba Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages Int. J. Mol. Sci. 15 2014 11510 11522
    • (2014) Int. J. Mol. Sci. , vol.15 , pp. 11510-11522
    • Warat, M.1    Szliszka, E.2    Korzonek-Szlacheta, I.3    Król, W.4    Czuba, Z.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.